Research ArticleClinical Studies
The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab
JACOPO GIULIANI and ANDREA BONETTI
Anticancer Research July 2019, 39 (7) 3971-3973; DOI: https://doi.org/10.21873/anticanres.13552
JACOPO GIULIANI
Department of Oncology, Mater Salutis Hospital, Legnago, Italy
ANDREA BONETTI
Department of Oncology, Mater Salutis Hospital, Legnago, Italy
In this issue
The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab
JACOPO GIULIANI, ANDREA BONETTI
Anticancer Research Jul 2019, 39 (7) 3971-3973; DOI: 10.21873/anticanres.13552
Jump to section
Related Articles
- No related articles found.